Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulation of Immune Response and Side Effects of Cancer Treatments by Aerobic Exercise: Role of Exercise Intensity

NCT04715061 is registered in ClinicalTrials.gov with Université de Sherbrooke as lead sponsor.

NCT NCT04715061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04715061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulation of Immune Response and Side Effects of Cancer Treatments by Aerobic Exercise: Role of Exercise Intensity
Lead sponsor
Université de Sherbrooke
Phase
Not applicable
Overall status
Completed
Start date
November 4, 2020
Completion date
October 4, 2022
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer stage iv